Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

KOSTENUIK, P·2005·Current Opinion in Pharmacology
DOI 10.1016/j.coph.2005.06.005

Cited by (280)

Items 201–280 of 280

  1. Die Rolle des RANK/RANKL/OPG-Signalwegs im Knochenstoffwechsel
    Lorenz Christian Hofbauer, Tilman D. Rachner · 2010 · Springer eBooks
  2. Osteoporosis
    Jane A. Cauley · 2012 · Elsevier eBooks
  3. Impact of short and long-term application of low-level laser therapy on mandibular alveolar process of osteoporotic rats – a Histological and Molecular Study
    Mai Osman El-Halwagy, Enas Hegazy, Hany K. Shalaby, Elham Mahmoud · 2025 · Lasers in Medical Science
  4. Tendon Transfers—How Do They Work?
    Thomas C. Dowd, Eric Michael Bluman · 2013 · Foot and Ankle Clinics
  5. Bone metabolism
    Humphrey P Rang, M.Maureen Dale, JM Ritter, RJ Flower · 2007 · Elsevier eBooks
  6. Blockade of Osteoclast-Mediated Bone Resorption With a RANKL-Inhibitor Enhances Bone Formation in a Rat Spinal Fusion Model
    Karin A. Payne, Nichole M. Shaw, Christopher B. Erickson, Peter Yarger, Yangyi Yu, Todd H. Baldini, Christopher J. Kleck, Vikas V. Patel, Evalina L. Burger · 2022 · Spine
  7. The osteogenic effects of sponges synthesized with biomaterials and nano-hydroxyapatite
    Woong Jin Lee, Kyoungjoo Cho, Gunwoo Jung, Aaron Youngjae Kim, Gyung Whan Kim · 2023 · Biomedical Physics & Engineering Express
  8. Bone metabolism regulation through RANK-RANKL-OPG system
    Neyro Bilbao Jl, Cano Sánchez A, Palacios Gil-Antuñano S, Servicio de Obstetricia · 2011
  9. Neue pathophysiologische Stoffwechselwege in der Osteoporose
    Elena Neumann · 2006 · Zeitschrift für Rheumatologie
  10. Current, new and emerging anti-resorptive drugs; antibody blockade of RANKL action
    Thomas John Martin · 2006 · BoneKEy-Osteovision
  11. Hypercalcemia Due to PTHrP
    Richard B. Kremer, David Goltzman · 2014 · Elsevier eBooks
  12. Response to: ‘Denosumab, cortical bone and bone erosion in rheumatoid arthritis’ by Rossini et al
    Tsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, Hisashi Yamanaka, Toshiyuki Yoneda, Takeshi Ohira, Naoki Okubo, Harry K. Genant, Désirée M F M van der Heijde · 2016 · Annals of the Rheumatic Diseases
  13. Mechanism of Action for Therapeutic Antibodies
    Yu Zhou, James D. Marks · 2016 · Wiley eBooks
  14. Chikungunya Virus Infection-Associated Bone and Joint Disease
    Brad A. Goupil · 2016
  15. Knee Bony Defects Reconstruction in Revision Total Knee Arthroplasty for Aseptic Loosening
    Ahmed Adel Khalifa · 2019 · Orthopedic Research Online Journal
  16. Rheuma und Knochenstoffwechsel
    Gabriel Dischereit, Uwe Lange · 2020 · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen
  17. The role of vitamin D and physical activity on osteopenia and osteoporosis
    Iulian Ștefan Holubiac · 2022 · Elsevier eBooks
  18. Validation of the therapeutic potential of soluble CD93 lectin-like domain in arthritis and its inhibitory role in inflammatory osteolysis
    Shang‐En Huang, Cheng‐Hsiang Kuo, Hua‐Lin Wu, Erna Sulistyowati, Fang-Tzu Lee, Chao‐Han Lai, Jwu‐Lai Yeh · 2025 · International Immunopharmacology
  19. Denosumab Withdrawal and Rebound Bone Resorption: Molecular Mechanisms and Approaches for Treatment
    Rajamohanan Jalaja Anish, Aswathy Nair · 2025 · Current Stem Cell Reports
  20. From Joint Loading to Osteoarthritis: A Multiscale Review of Knee Mechanobiology and Digital Modelling
    Mikołaj Stańczak, Bartłomiej Kacprzak, Magdalena Hagner-Derengowska · 2026 · International Journal of Molecular Sciences
  21. Insulin-Like Growth Factor-1 and Osteocalcin Are Correlated with Markers of Osteoporosis in Postmenopausal Women with Type-2 Diabetes
    Maher Abd EL-Nabi Kamel, Madiha H. Helmy, Anna N. Abou Rayah, Nevine Mohannad, Huda Mahmoud Hania · 2013 · Open Journal of Endocrine and Metabolic Diseases
  22. HOW OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IS RELATED TO HEARING LOSS?
    AikateriniDrylli MD. · 2016 · International Journal of Advanced Research
  23. Where are we in targeting hypoxia-induced pathways in inflammatory arthritis? Current understanding, insights, and future directions
    Lisa E. Wang, Akihiro Nakamura · 2024 · International Immunopharmacology
  24. Pharmacological osteonecrosis in maxillofacial surgery, period 2013-2019
    Alejandra Giselle Juárez Rebollar, Arlen Colin Ordaz, Daniel Juárez-Rebollar · 2021 · Revista de la Sociedad Española del Dolor
  25. Теоретическая модель перестройки костной ткани
    2015 · Российский журнал биомеханики
  26. Pharmacotherapy of Bone Loss in Postmenopausal Women: Focus on Denosumab
    Alejandro Román-Gonzaléz, Kathryn E. Ackerman · 2009 · Clinical Medicine Therapeutics
  27. Reduced order modelling of bone resorption and formation.
    Adam Moroz · 2011 · DMU Open Research Archive (De Montfort University)
  28. Antibodies in Phase I/II/III: Cancer Therapy
    Peter Markus Deckert · 2007
  29. Function of cells producing type I collagen: potentialinfluence of the vasculature
    Sarah E. B. Taylor · 2011 · Doctoral thesis, UCL (University College London).
  30. Estudio histológico de las reacciones biológicas del tejido óseo frente a biomateriales basados en monetita
    Lorena Benito-Garzón · 2012
  31. Monoclonal Antibody Cancer Treatments in Phase III Clinical Trials
    Ulf Petrausch, Peter Markus Deckert · 2014
  32. Osteoporosis and sarcopenia in older adults
    Didier Chalhoub · 2015 · D-Scholarship@Pitt (University of Pittsburgh)
  33. Denosumab for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy
    Dan Feng, Dong Mei Wei, Juan Zhou, Xu Han, Fuxia Chen, Fang Fang · 2010 · Cochrane Database of Systematic Reviews
  34. Ciblage thérapeutique des tumeurs osseuses primitives par transfert de gène
    François Lamoureux · 2008 · OpenGrey (Institut de l'Information Scientifique et Technique)
  35. Mammary Gland-Specific Expression of Biologically Active Human Osteoprotegerin in Transgenic Mice
    Yoon-Young Sung, Chul-Sang Lee · 2013 · Development & Reproduction
  36. Denosumab for treatment of osteoporosis in postmenopausal women
    Ove Törring · 2011 · Clinical Investigation
  37. Commentary: A single biomarker in a complex metabolic pathway
    Jane A. Cauley · 2012 · International Journal of Epidemiology
  38. Le pied diabétique
    Daryoush Bassiri · 2007 · Annales d Endocrinologie
  39. et cible thérapeutique dans l'ostéoporose
    Pierre J. Marie, Philippe Halbout · 2008
  40. Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
    Sity Aishah Mansur · 2015 · UTHM Institutional Repository (Universiti Tun Hussein Onn Malaysia)
  41. New strategies of treatment of postmenopausal osteoporosis
    Anna Sobczuk, Katarzyna Sobczuk, Tomasz Pertyński · 2011 · Menopause Review/Przegląd Menopauzalny
  42. Receptor‐Fc and Ligand Traps as High‐Affinity Biological Blockers: Development and Clinical Applications
    Aris N. Economides, Neil Stahl · 2013 · Wiley eBooks
  43. " Papel do Denosumab no Tratamento da Doença Óssea Metastática".
    Patrícia Isabel Nunes Cruz · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  44. BIOCHEMICAL ANALYSIS AND BONE REMODELING IN RESPONSE TO OOPHORECTOMY AND AQUATIC TRAINING
    Helena Ribeiro Souza, Ana Paula Girol, Adriana Paula Sanchez Schiaveto, Mairto Roberis Geromel, Melina Mizusaki Iyomasa-Pilon, Maurício Ferraz de Arruda · 2016 · Acta Ortopédica Brasileira
  45. The Effects of a Single Bout of Plyometric Exercise on Anabolic and Catabolic Osteokines in Girls and Adolescents
    Jennifer Dekker · 2016 · Brock University Digital Repository (Brock University)
  46. Fibroblastäre Modulatoren der Knochendestruktion
    Berno Dankbar, Thomas Pap · 2016 · Zeitschrift für Rheumatologie
  47. MEDICAL MANAGEMENT AND PHARMACOLOGY UPDATE The relationship of denosumab pharmacology and osteonecrosis of the jaws
    John Malan, Erich Naumann, O. Ross Beirne · 2012
  48. Evolution and Progression of Arterial Occlusive Disease in Patients with Diabetes
    Stephanie Wu · 2008 · Journal for Vascular Ultrasound
  49. New Approaches to Osteoporosis Therapeutics
    Rivka Dresner–Pollak, Selwyn Aubrey Stoch, Michael Rosenblatt · 2008 · Elsevier eBooks
  50. Neue pathophysiologische Stoffwechselwege in der Osteoporose : Zukünftige innovative Therapieansätze?
    Elena Neumann · 2006 · Zeitschrift für Rheumatologie
  51. Icariin Combined with Adipose-Derived Stem Cells Ameliorated Osteoporosis in Postmenopausal Rats
    Ying Sun, Dongbo Wang, Dao Tang, Yanjie Liu, Fei Xu, Zhengguang Wang, Ziqi Liu · 2020
  52. Denosumab in the Treatment of Postmenopausal Women with Osteoporosis: Fracture Outcomes, BMD, and Morphological Assessment
    Rachel B. Wagman · 2021 · Springer eBooks
  53. Faculty Opinions recommendation of Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss.
    Robert Carter · 2011 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  54. Desenvolvimento de scaffolds de quitosana complexada com xantana para potencial aplicação na regeneração de tecidos ósseos guiada pelo periósteo
    Renata Francielle Bombaldi de Souza · 2018
  55. Osteoporosis
    Jane A. Cauley · 2012 · Springer eBooks
  56. Osteosarcopenia
    Ben Kirk, Jesse Zanker, Steven Phu, Gustavo Duque · 2021
  57. Denosumab (Prolia®)
    Torsten L. Meyer · 2014
  58. Denosumab
    Michael A. Bolognese · 2013
  59. Osteoporosis
    Aaroop Haridas, Seth Mark Berney · 2019 · Springer eBooks
  60. Denosumab for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy
    Dan Feng, Dong Mei Wei, Juan Zhou, Xu Han, Fuxia Chen, Fang Fang · 2010 · Cochrane Database of Systematic Reviews
  61. Intermittent hypoxia induces mandibular growth arrest and invokes a different response in condylar and tibial cartilage in infant rats
    Kochakorn Lekvijittada, Chidsanu Changsiripun · 2019
  62. Avaliação da osteoprotegerina sérica e seus polimorfismos genéticos em pacientes com arterite de Takayasu e sua correlação com fatores de risco cardiovascular
    Camila da Silva Cendon Duran · 2024
  63. Fixation of total knee replacement : Effects of bone specific drugs and tourniquet use
    Håkan Ledin · 2024 · Linköping University medical dissertations
  64. Biosimilar
    Ya Wang, Qinqin Xu, Xiangyu Zhang · 2024 · Springer eBooks
  65. Exosome-derived Uc.339 as a potential biomarker for bone metastasis from pulmonary adenocarcinoma
    Weiqiang Lai, Jinchang Huang, Xuwang Lai, Yuli Wang · 2025 · Tissue and Cell
  66. Research Progress on Signaling Pathways Involved in Treating Osteoporosis with Isopsoralen
    Huan Jin, Bo Shuai, Cai Ping Huang, Di Wang, Ziyi He, Lin Shen, Man Chen, Zixian Wang · 2025 · Current Traditional Medicine
  67. Monoclonal Antibodies and Osteonecrosis of the Jaw: A Systematic Review of Risk, Incidence, and Clinical Management in Dentistry
    Gianna Dipalma, Alessio Danilo Inchingolo, Mariafrancesca Guglielmo, Irene Palumbo, Lilla Riccaldo, Roberta Morolla, Francesco Inchingolo, Daniela Di Venere, Andrea Palermo, Angelo Michele Inchingolo · 2025 · International Journal of Dentistry
  68. Osteoporosis Drugs: Old and New Drugs
    Boselli Federica, Maria Grazia Radaelli · 2025 · Springer eBooks
  69. Additional file 1 of Gene network analysis to determine the effect of hypoxia-associated genes on brain damages and tumorigenesis using an avian model
    Hamed Kharrati-Koopaee, Ebrahimie, Esmaeil, Dadpasand, Mohammad, Niazi, Ali, Tian, Rugang, Esmailizadeh, Ali · 2021 · Figshare
  70. Additional file 2 of Gene network analysis to determine the effect of hypoxia-associated genes on brain damages and tumorigenesis using an avian model
    Hamed Kharrati-Koopaee, Ebrahimie, Esmaeil, Dadpasand, Mohammad, Niazi, Ali, Tian, Rugang, Esmailizadeh, Ali · 2021 · Figshare
  71. Sex hormones and injury in female athletes
    Umile Giuseppe Longo, Aurora Citerni di Siena, Ginevra Andreucci, Alessandro de Sire, Silvia Migliaccio, Umberto Tarantino, Pieter P. R. N. d’Hooghe · 2025 · International Journal of Bone Fragility
  72. Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic mice
    Vagelis E. Rinotas, Eleftheria-Dimitra Ntouskou, Melina Dragolia, Vasileios Ntafis, Maria P. Yavropoulou, Athanasios D. Anastasilakis, Polyzois Makras, Eleni K. Douni · 2026 · Frontiers in Endocrinology
  73. Current outlook on the use of monoclonal antibody therapies for osteoporosis
    Mohammed S. Almohaya, Mohammed S. Almehthel, David L. Kendler · 2026 · Expert Opinion on Biological Therapy
  74. Parodontite et inflammation : approche clinique et biologique du rôle du lymphocyte B
    Julien Demoersman · 2018
  75. Impact de la correction de fonction de CFTR sur le phénotype ostéoclastique dans la pathologie osseuse liée à la mucoviscidose
    Johan Sergheraert · 2023 · theses.fr (ABES)
  76. Diet-derived quercetin and its molecular interactions in rheumatoid arthritis: a systematic review
    Ghaleb Oriquat, Waleed K. Abdulsahib, Sajida Hussein Ismail, R. Roopashree, Swati Mishra, Krishnakumar Samikan, Vimal Arora, Ashish Singh Chauhan, Zafar Aminov · 2026 · Nutrition & Food Science
  77. Osteoporosis
    Jane A. Cauley, Lauren S. Roe · 2026 · Elsevier eBooks
  78. Osteoimmune senescence in aging bone: from inflammaging dogma to cell-type-specific therapeutic windows
    Lan Zhang, Yao Yao, Jinxu Chen · 2026 · Frontiers in Immunology
  79. Osteoporoseprophylaxe unter Androgendeprivationstherapie
    N. Rolfes, Gerd Lümmen · 2011 · Der Urologe
  80. Behandlung von symptomatischen Knochenmetastasen bei urologischen Tumoren
    N. Rolfes, Gerd Lümmen · 2014 · Der Urologe